Haisco Pharmaceutical Group Company Description

Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals in China.

The company offers cycloporol, dolasetron mesylate, polyene phosphatidylcholine, compound amino acid, and methylprednisolone sodium injections, as well as flupenthixol melitracen tablets.

It offers its products in various therapeutic fields, including anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular.

The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016.

Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.

Haisco Pharmaceutical Group Co., Ltd.

Country	China
Founded	2005
Industry	Biotechnology
Sector	Healthcare
Employees	5,448
CEO	Xiu Lian Fan

Contact Details

Address: No.17, Sanxiang Avenue Shannan, 856000 China
Phone	86 89 3783 4865
Website	haisco.com

Stock Details

Ticker Symbol	002653
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100001BC7
SIC Code	2834

Key Executives

Name	Position
Xiu Lian Fan	MD, GM and Director
Peng Duan	Financial Director
Wei Zhang	Deputy GM and Director
Pangke Yan	Deputy GM and Director
Han Bing Liu	Human Resources Manager